Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 12Terminated 5Withdrawn 3Unknown 1Recruiting 1

Sponsor Class

OTHER 7INDUSTRY 5

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Neoplasms 474Carcinoma, Non-Small-Cell Lung 449Breast Neoplasms 331Neoplasm Metastasis 243Colorectal Neoplasms 214Melanoma 213Leukemia, Myeloid, Acute 191Multiple Myeloma 180Recurrence 169Ovarian Neoplasms 169Prostatic Neoplasms 163Lymphoma, Non-Hodgkin 149Lung Neoplasms 134Pancreatic Neoplasms 125Lymphoma 124Carcinoma, Renal Cell 112Leukemia, Lymphocytic, Chronic, B-Cell 111Squamous Cell Carcinoma of Head and Neck 110Stomach Neoplasms 92Carcinoma, Hepatocellular 89Lymphoma, Large B-Cell, Diffuse 88Leukemia 88Triple Negative Breast Neoplasms 86Lymphoma, Follicular 82Head and Neck Neoplasms 79Glioblastoma 75Myelodysplastic Syndromes 70Urinary Bladder Neoplasms 68Small Cell Lung Carcinoma 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 55

Interventions

morphine, naltrexone combination 1Tapentadol 1Naltrexone 1Morphine 16'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Chronic Pain × Clear all
NCT04287075 2024-03-26

Rethink Pain

Axogen Corporation

Terminated
8 enrolled

Neuralgia, Neuroma, Peripheral Nervous System Diseases, Peripheral Nerve Injuries, Chronic Pain

NCT01964378 2021-07-15

CORAL

Tris Pharma, Inc.

Phase 3 Terminated
200 enrolled 37 charts

Cancer Pain, Neoplasms, Pain, Chronic Pain

NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated
31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

NCT01100437 2012-07-13

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Pfizer

Phase 4 Terminated
14 enrolled 18 charts

Substance Withdrawal Syndrome, Chronic Pain

NCT00126789 2012-06-05

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

ZARS Pharma Inc.

Phase 3 Terminated
24 enrolled

Cancer Pain, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡